A Multi-country & Multi-center Study to Assess the Efficacy, Immunogenicity & Safety of Two Doses of GSK Biologicals' Oral Live Attenuated HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants.
Phase of Trial: Phase III
Latest Information Update: 03 Nov 2016
At a glance
- Drugs RIX 4414 (Primary) ; Poliovirus vaccine live oral
- Indications Gastroenteritis; Poliomyelitis; Rotavirus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 09 Oct 2008 Checked against ClinicalTrials.gov record - last updated 9 Oct 2008.
- 30 Jul 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
- 05 Nov 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History